Beneficial effects of L-carnitine in myoblastic C2C12 cells. Interaction with zidovudine (Q44430775)

2 December 2017

title

Beneficial effects of L-carnitine in myoblastic C2C12 cells. Interaction with zidovudine (English)

1 reference

2 December 2017

Béatrice Georges

1

1 reference

2 December 2017

Stéphane Galland

2

1 reference

2 December 2017

Caroline Rigault

3

1 reference

2 December 2017

Françoise Le Borgne

4

1 reference

2 December 2017

Jean Demarquoy

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

published in

Biochemical Pharmacology

1 reference

2 December 2017

volume

65

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

1483-1488

1 reference

Functional characterization of intestinal L-carnitine transport

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Carnitine: metabolism and clinical chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Adverse effects of antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Carnitine transport into muscular cells. Inhibition of transport and cell growth by mildronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Characteristics of L-carnitine transport by lactating rat mammary tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900110-2

10.1016/S0006-2952(03)00110-2

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference